The INVICTUS rheumatic heart disease research program: Rationale, design and baseline characteristics of a randomized trial of rivaroxaban compared to vitamin K antagonists in rheumatic valvular disease and atrial fibrillation. (2020)
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1016/j.ahj.2020.03.018
PubMed Identifier: 32474206
Publication URI: http://europepmc.org/abstract/MED/32474206
Type: Journal Article/Review
Volume: 225
Parent Publication: American heart journal
ISSN: 0002-8703